Intraocular Pressure in the Middle East
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Heijl A, Leske M, Bengtsson B, Hyman L, Bengtsson B, Hussein M
. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002; 120(10):1268-79.
DOI: 10.1001/archopht.120.10.1268.
View
2.
Kass M, Heuer D, Higginbotham E, Johnson C, Keltner J, Miller J
. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002; 120(6):701-13; discussion 829-30.
DOI: 10.1001/archopht.120.6.701.
View
3.
Nemesure B, Wu S, Hennis A, Leske M
. Factors related to the 4-year risk of high intraocular pressure: the Barbados Eye Studies. Arch Ophthalmol. 2003; 121(6):856-62.
DOI: 10.1001/archopht.121.6.856.
View
4.
Leske M, Wu S, Hyman L, Nemesure B, Hennis A, Schachat A
. Four-year incidence of visual impairment: Barbados Incidence Study of Eye Diseases. Ophthalmology. 2004; 111(1):118-24.
DOI: 10.1016/j.ophtha.2003.04.002.
View
5.
Klein B, Klein R
. Intraocular pressure and cardiovascular risk variables. Arch Ophthalmol. 1981; 99(5):837-9.
DOI: 10.1001/archopht.1981.03930010837009.
View